Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 5/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.55 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.50 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1041473 | 1.00 | OPRL1 (0.55) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| SCHEMBL29195226 | 1.00 | OPRL1 (0.55) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| SCHEMBL4556223 | 1.00 | OPRL1 (0.55) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| Hydrogen Peroxide SCHEMBL14842577 | 1.00 | OPRL1 (0.55) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| SCHEMBL1040024 | 1.00 | OPRL1 (0.55) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| SCHEMBL16469256 | 1.00 | OPRL1 (0.55) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| SCHEMBL1109741 | 0.97 | OPRL1 (0.57) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| SCHEMBL1724862 | 0.92 | OPRL1 (0.57) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| Ethylene Glycol SCHEMBL28317982 | 0.91 | OPRL1 (0.49) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| Ammonia Solution, Strong SCHEMBL29195223 | 0.90 | OPRL1 (0.55) | OPRL1OPRM1OPRK1OPRD1AKR1C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117720466-B | 2 '-Acetyl-2', 3 '-dihydro-4'H-spiro [ cyclohexane-1, 1 '-isoquinoline ] -4' -ketone compound and preparation method and application thereof | 承德医学院 | 2026-05-19 | — | — | CN | claimed |
| CN-119591988-A | High-voltage cable for new energy automobile | 湖南鸿丰泰电子有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-119529660-A | Scratch-resistant wear-resistant anti-burst UV oil and preparation method thereof | 惠州市博尔美新材料有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119505087-A | Two-photon polymerization 3D printing photoresist based on dynamic boric acid ester bond, and preparation method and application thereof | 中国工程物理研究院激光聚变研究中心 | 2025-02-25 | — | — | CN | claimed |
| CN-118085743-A | Basalt fiber composite material and preparation method and application thereof | 合肥联宝信息技术有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117720466-A | 2 '-acetyl-2', 3 '-dihydro-4'H-spiro [ cyclohexane-1, 1 '-isoquinoline ] -4' -ketone compound and preparation method and application thereof | 承德医学院 | 2024-03-19 | — | — | CN | claimed |
| CN-114752210-B | Ultraviolet curing electrolyte, preparation method of electrolyte membrane and electrochromic device | 江苏慧智新材料科技有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117466840-A | UV-curable modified epoxy vegetable oil acrylic ester, preparation method thereof and coating | 华南理工大学 | 2024-01-30 | — | — | CN | claimed |
| WO-2023241720-A1 | SYSTEM FOR PROCESSING SAMPLES AND METHOD FOR PREPARING SAME | 上海高探生物科技有限公司 | 2023-12-21 | — | — | WO | claimed |
| CN-116969953-A | Diphenyl pyrrolo-pyrrole-dione derivative, pigment composition and application thereof | 山东凯瑞尔光电科技有限公司 | 2023-10-31 | — | — | CN | claimed |
| US-20110301387-A1 | Process For Producing Phenol | EXXONMOBIL CHEMICAL PATENTS INC. | 2011-12-08 | — | — | US | claimed |
| WO-2010098916-A2 | PROCESS FOR PRODUCING PHENOL | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-09-02 | — | — | WO | claimed |
| US-20050027008-A1 | Cancer remedy comprising anthranilic acid derivatives as active ingredient | TEIJIN LIMITED | 2005-02-03 | — | — | US | claimed |
| EP-0858329-B1 | NOVEL STABLE LIQUID PARACETAMOL COMPOSITIONS, AND METHOD FOR PREPARING SAME | SCR PHARMATOP (FR) | 2003-06-04 | — | — | EP | claimed |
| US-6028222-A | A PAIN RELIEF DRUG COMPRISING AN AQUEOUS MEDIUM INCLUDING A BUFFERING AGENT AND A FREE RADICAL SCAVENGER AND A RADICAL ANTAGONIST; AS INJECTABLE COMPOSITIONS FOR RELIEVING PAIN | SCR PHARMATOP (FR) | 2000-02-22 | — | — | US | claimed |
| CN-1204960-A | Novel stable preparation use paracetamol as base and method for preparing same | SCR PHARMATOP (FR) | 1999-01-13 | — | — | CN | claimed |
| EP-0858329-A1 | NOVEL STABLE LIQUID PARACETAMOL COMPOSITIONS, AND METHOD FOR PREPARING SAME | SCR Pharmatop (FR) | 1998-08-19 | — | — | EP | claimed |
| WO-1998005314-A1 | NOVEL STABLE LIQUID PARACETAMOL COMPOSITIONS, AND METHOD FOR PREPARING SAME | SCR PHARMATOP (FR) | 1998-02-12 | — | — | WO | claimed |
| US-5066403-A | Polytetrafluoroethylene bonded to perflurosulfonic acid polymer | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF COMMERCE (US) | 1991-11-19 | — | — | US | claimed |
| EP-0223635-A1 | Phenylcyclohexyl dicarboxylates and process for their preparation | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1987-05-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110301387-A1 | Process For Producing Phenol | NOX4, CYP2E1, SCO2 | OPRL1 2771/4885OPRM1 1971/4885OPRK1 2268/4885 |
| US-20050027008-A1 | Cancer remedy comprising anthranilic acid derivatives as active ingredient | CA9, HCCS, CA7 | OPRL1 2982/4885OPRM1 2754/4885OPRK1 3910/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.